Psychosocial barriers and facilitators to clinical trial enrollment and adherence for adolescents with cancer

42Citations
Citations of this article
63Readers
Mendeley users who have this article in their library.

Abstract

Adolescents (aged 15-19 years) have not experienced the same survival gains as children and older adults diagnosed with cancer. Poor clinical trial enrollment and adherence rates among adolescents may account for some of this disparity. Although biological, regulatory, systemic, and practice-related challenges to clinical trial enrollment and adherence have been examined, studies of psychosocial factors, which can serve as barriers or facilitators to enrollment and adherence, are limited. To bring attention to these psychological factors, we reviewed existing literature on psychosocial barriers and facilitators that can affect an adolescent's decision to enroll and adhere to a clinical trial. We also provide potential strategies to address psychosocial factors affecting clinical trial accrual and adherence. Copyright © 2014 by the American Academy of Pediatrics.

Cite

CITATION STYLE

APA

Buchanan, N. D., Block, R., Smith, A. W., & Tai, E. (2014, June 1). Psychosocial barriers and facilitators to clinical trial enrollment and adherence for adolescents with cancer. Pediatrics. American Academy of Pediatrics. https://doi.org/10.1542/peds.2014-0122I

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free